-
Eldecalcitol, Endothelial Ferroptosis, and T2DOP
2026-09-11
The 2025 study identifies endothelial ferroptosis as a mechanistic link between the high-glucose/high-fat environment of type 2 diabetes and impaired bone vascular–osteogenic coupling. Its data support an ED71-sensitive SOCE/O-GlcNAcylation pathway, while also providing a framework for connecting lipid peroxidation, endothelial dysfunction, and type 2 diabetic osteoporosis.
-
ASB3-MAVS Degradation in Antiviral Immunity
2026-09-11
The 2024 reference study identifies ASB3 as an E3 ubiquitin ligase that weakens antiviral innate immunity by promoting K48-linked ubiquitination and proteasomal degradation of MAVS. Its combined gain-of-function, loss-of-function, mechanistic, and animal infection experiments position ASB3 as a previously unrecognized regulatory checkpoint in RIG-I-like receptor signaling.
-
Phosbind Acrylamide for Protein Phosphorylation
2026-09-10
Phosbind Acrylamide is a phosphate-binding reagent for antibody-free SDS-PAGE phosphorylation detection. Product specifications support mobility-shift analysis of phosphorylated proteins from 30–130 kDa under neutral physiological conditions, while the cited rice study provides a biologically relevant case involving ABA, OsCDPK24, and OsANN4.
-
CD44 Metabolic Rewiring in IDH-Mutant Leukemia
2026-09-10
The reference study identifies CD44-mediated metabolic rewiring as a dependency of IDH-mutant leukemia, linking pentose phosphate pathway activity and NADPH production to sustained R-2-hydroxyglutarate synthesis. Its isogenic CRISPR-based design supports a mechanistic rationale for combining mutant-IDH inhibition with CD44 blockade in acute myeloid leukemia research.
-
MnTBAP Chloride and the Logic of Redox Rescue
2026-09-09
Mitochondrial superoxide is both a source of cellular injury and a regulator of inflammatory signaling. This thought-leadership perspective explains how MnTBAP Chloride can help translational researchers test that relationship across oxidative stress, mitochondrial dysfunction, neuroinflammation, and behavior models while preserving appropriate boundaries around route, timing, and preclinical evidence.
-
AZD8055: Practical mTOR Inhibitor Workflow
2026-09-09
AZD8055 is a selective ATP-competitive mTOR inhibitor for controlled studies of mTORC1 and mTORC2 signaling, cancer cell proliferation, and metabolism. This dossier-based guide supports assay preparation, handling, QC, and interpretation, but the compound should not be used as stand-alone evidence for clinical efficacy.
-
Dihydroethidium for Superoxide Assays
2026-09-08
Dihydroethidium (DHE), or hydroethidine, converts live-cell redox changes into a practical red-fluorescence readout for superoxide-associated oxidative stress. This guide connects assay setup and troubleshooting with ferroptosis-focused research, including the Keap1–Nrf2–GPX4 findings reported in acute lung injury.
-
Hoechst 33342/PI Double Staining Kit Guide
2026-09-08
The Hoechst 33342/PI Double Staining Kit (K2237) supports fluorescence-based comparison of nuclear morphology and membrane integrity in cultured cells. It is intended for scientific research workflows, not diagnostic or medical use, and the supplied dossier does not establish a specific disease model or cell-death mechanism.
-
10074-G5 Workflow for c-Myc Cancer Research
2026-09-07
Build a mechanistic cancer research workflow around 10074-G5, from DMSO stock preparation through c-Myc/Max engagement, apoptosis, cell cycle, and pathway readouts. The strategy connects miR-196a-driven esophageal adenocarcinoma biology with practical dose-response and tumor regression studies while separating reported product benchmarks from experiment-specific optimization.
-
BIBP 3226 Trifluoroacetate for Y1R Assays
2026-09-05
BIBP 3226 trifluoroacetate enables controlled interrogation of NPY Y1R and NPFF-linked signaling in cAMP, neuronal, and cardiomyocyte workflows. Its nanomolar rat Y1R affinity makes it especially useful for testing the leptin–NPY–Y1R axis implicated in adipose-related arrhythmia, while careful receptor and vehicle controls help distinguish mechanism from assay artifact.
-
Nurr1+ Neuron Development in the Rat Claustrum
2026-09-05
Fang, Wang, and Naumann mapped the developmental emergence and birth timing of Nurr1-positive neurons across the rat claustrum, endopiriform regions, and lateral cortex. By combining EdU labeling with Nurr1 in situ hybridization, the study resolved sequential neurogenesis and identified spatial gradients that refine anatomical models of claustrum development.
-
Brassinolide: Plant Signaling and Research Uses
2026-09-04
Brassinolide, also called 24-Epibrassinolide, is a sterol-derived plant hormone used to study plant development and stress responses. Research dossiers also describe apoptosis-associated effects in PC-3 prostate cancer cells and blood-glucose reduction in an alloxan-induced diabetic rat model, but these findings do not establish human therapeutic efficacy.
-
Ranolazine for Reliable Cell-Assay Workflows
2026-09-04
A scenario-based guide to using Ranolazine (SKU A8510) in cell viability, proliferation, and cytotoxicity workflows. It explains formulation, vehicle controls, metabolic readout interpretation, protocol optimization, and practical criteria for selecting a reliable research-grade supplier.
-
Cyclopamine: Hedgehog Signaling Workflows
2026-09-03
Cyclopamine enables time-controlled Smoothened perturbation across cancer and developmental models, from apoptosis induction in colorectal tumor cells to comparative genital-tubercle assays. This guide connects practical dosing, morphology, and gene-expression workflows with troubleshooting strategies for more reproducible Hedgehog pathway experiments.
-
Dual-Action Inhibitors Accelerate p38α Dephosphorylation
2026-09-02
This preprint shows that selected kinase inhibitors can both inhibit p38α catalytic activity and accelerate removal of its activation-loop phosphate by WIP1. Biochemical and crystallographic evidence links this dual action to stabilization of an inactive activation-loop conformation, suggesting a structure-guided strategy for improving kinase-inhibitor specificity.